GlassScriptPhysician profile
John Ellis Marshall
NPI 1518596048
$18,057.50
in general payments reported to CMS, 2019-2025
31 companies · $6,450 in 2025
The $6,450 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,708 · 2023: $2,563 · 2024: $7,336 · 2025: $6,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,816 · Travel and Lodging: $5,729 · Consulting Fee: $2,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,815.85 |
| Travel and Lodging | $5,728.55 |
| Consulting Fee | $2,805.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,404.10 | 2022-2025 | Prostep, Inbone, Augment Injectable |
| Forma Medical | $2,867.28 | 2025 | Optimalmtp |
| Treace Medical Concepts, INC. | $2,126.41 | 2024-2025 | |
| Linvatec Corporation | $1,460.86 | 2025 | Biobrace 23mm, Quantum, Colink Neofuse |
| Arthrex, INC. | $1,347.15 | 2024 | |
| Mid-Atlantic Surgical Systems, LLC | $1,246.60 | 2022-2023 | |
| Mirus, LLC | $1,044.73 | 2024 | Atlas Plating System |
| Core Surgical Group | $776.51 | 2024-2025 | |
| Kerecis Limited | $702.32 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $632.20 | 2023-2025 | Stravix, Grafix, Grafix Pl |
| Exactech, INC. | $405.69 | 2023 | |
| Nevro Corp. | $325.67 | 2024 | Senza |
| Zimmer Biomet Holdings, INC. | $213.23 | 2024 | Biocue, Tapestry |
| Paratek Pharmaceuticals, INC. | $199.60 | 2024-2025 | Nuzyra |
| Ibsa Pharma INC. | $174.30 | 2023-2024 | Licart, Tirosint |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $141.78 | 2023 | Strensiq |
| Integra Lifesciences Corporation | $132.71 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $129.75 | 2024 | Mtp |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2023 | Exparel |
| Orthofix Medical, INC. | $103.89 | 2024-2025 | Physio-Stim |
| Averitas Pharma INC. | $94.95 | 2023-2024 | Qutenza |
| Restor3d, INC. | $89.69 | 2024 | |
| Bioventus LLC | $76.16 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $65.57 | 2025 | Krystexxa |
| Biocomposites INC | $40.07 | 2024 | |
| Convatec INC. | $39.68 | 2023 | |
| Globus Medical, INC. | $23.06 | 2025 | Senza |
| Anika Therapeutics, INC. | $22.23 | 2024 | Toe Motion, Anika/Parcus, Integrity |
| Depuy Synthes Sales INC. | $16.18 | 2024 | |
| Avanos Medical | $16.07 | 2025 | On-Q Pump and Accessories |
| Kowa Pharmaceuticals America, INC. | $14.06 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.